Q3 revenue on record pace; SOLIS & COR to launch late Q4; Terravis pursuing validation and global partnerships West Seneca, New York, Sept. 23, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a […]
In partnership with RxERP Financial, the program offers up to $350,000 per pharmacy and $1 million per wholesaler or manufacturer through trusted third-party financing partners, strengthening cash flow and supply chain resilience. TAMPA, FL / September […]
LIVERMORE, Calif., Sept. 22, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, has delivered its next generation, state-of-the-art Honey Badger 50™ (“HB50”) portable power units to […]
NEXT SUPER STOCK Worksport (NASDAQ: WKSP) can increase +10X from $3.50 to $50.00 over the next 12 months. Here’s how: revenue $20 mil run rate – growing at +100% over last year..INFLECTION POINT w new […]
NEXT SUPER STOCK Wellgistics (NASDAQ: WGRX) Scaling to $250 Mil+ Revenue next 12 mos. is “Extremely DOABLE” says CEO DO. THE. MATH. This could be worth 4X multiple = $1 BILLION++ valuation = $15.00 stock […]
NEXT SUPER STOCK: Wellgistics (NASDAQ: WGRX) is an emerging leader in $600 BILLION Pharma distribution market in the US. $WGRX is a young company at INFLECTION POINT for EXPLOSIVE GROWTH phase with path to $250 […]
Next Super Stock Advent Technologies (NASDAQ: ADN) Hydrogen Fuel Cells could be the future of ENERGY for Aviation, Robots, Drones, Ships and more – $100 BILLION Market Opportunity. $ADN is UP +200% since we launched […]
Next Super Stock Advent Technologies (NASDAQ: ADN) Hydrogen Fuel Cells could be the future of ENERGY for Aviation, Robots, Drones, Ships and more – $100 BILLION Market Opportunity. $ADN is UP +200% since we launched […]
NEXT SUPER STOCK Hoth Therapeutics (NASDAQ: HOTH) is advancing a biotech portfolio with “multiple shots on goal” for billion dollar market opportunities. (NASDAQ: HOTH) is trading at deep value, near it’s current CASH position. This offers […]
LIVERMORE, Calif., Sept. 09, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is proud to announce a major technological breakthrough in its strategic collaboration […]
NEW YORK, Sept. 10, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced it has submitted its Clinical Trial Application (CTA) to the European Medicines Agency (EMA) to expand its ongoing Phase II trial of […]
Company Achieves Consistent Growth With Four Straight Record Months; Gross Margin Expands 2,000+ Basis Points in Three Quarters; Production Hits Strongest Levels to Date West Seneca, New York, Sept. 09, 2025 — Worksport Ltd. (NASDAQ: […]
Company Reaffirms ≥$20 Million 2025 Revenue Target and Highlights Clear Path to Near-Term Operational Cash Flow Positivity West Seneca, New York, Aug. 13, 2025 — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based […]
NEW YORK, Sept. 2, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced combined positive findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT, including compelling anti-tumor efficacy, a clean […]
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif., August 25, 2025—-Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
